What does fact checked mean?
At Healthfully, we strive to deliver objective content that is accurate and up-to-date. Our team periodically reviews articles in order to ensure content quality. The sources cited below consist of evidence from peer-reviewed journals, prominent medical organizations, academic associations, and government data.
- Oligomeric Proanthocyanidin Complexes: History, Structure, and Phytopharmaceutical Applications
- Oligomeric Proanthocyanidin Complexes: History, Structure, and Phytopharmaceutical Applications
The information contained on this site is for informational purposes only, and should not be used as a substitute for the advice of a professional health care provider. Please check with the appropriate physician regarding health questions and concerns. Although we strive to deliver accurate and up-to-date information, no guarantee to that effect is made.
The use of supplements as a treatment for attention deficit hyperactivity disorder (ADHD) has grown in popularity in recent years 1. The hallmark symptoms of the disorder are difficulty controlling actions and behavior, presenting as hyperactivity and impulsivity, as well as difficulties with concentration and sustaining attention. Though typically managed with prescription stimulant medications and behavioral therapy, dietary supplements may help, too.
If you are experiencing serious medical symptoms, seek emergency treatment immediately.
OPCs and OPC-3 Isotonix
Oligomeric proanthocyanidins (OPCs) are compounds derived from plant-based flavonoids 2. They are in berries, nuts, flowers, beans and red wine, but the highest concentrations occur in seeds, skin and bark of particular plants. Their chemical structure is simpler than other flavonoids, making them more easily absorbed into the bloodstream. As they contain strong antioxidants, OPCs help to act against fat and water-soluble oxidizing agents, reduce inflammation and aid proteins. OPCs are helpful in supporting the vascular system, and relieving allergies, asthma, and symptoms of Alzheimer’s and Parkinson’s disease, among other things. They may also be helpful in treating ADHD. OPC-3 Isotonix differs in its delivery method. Isotonix is a method of delivering the medication once in the body. It allows quick and efficient absorption of the compounds into the bloodstream.
- Oligomeric proanthocyanidins (OPCs) are compounds derived from plant-based flavonoids 2.
- OPCs are helpful in supporting the vascular system, and relieving allergies, asthma, and symptoms of Alzheimer’s and Parkinson’s disease, among other things.
OPC-3 Effectiveness for ADHD
Can flaxseed oil help treat symptoms of ADHD?
Learn More
A study published in the "Journal of Academic Child and Adolescent Psychiatry" examined the use of OPC in children with ADHD. Its use reportedly helped reduce symptoms of inattention and distraction significantly more than symptoms of impulsive and hyperactive behavior, but changes were seen in both. According to the "Alternative Medicine Review," use of OPC for ADHD is mostly based on anecdotal reports suggesting that symptoms improved while patients were taking OPC supplements. An animal study found that OPC supplements helped improve memory and learning problems as well.
- A study published in the "Journal of Academic Child and Adolescent Psychiatry" examined the use of OPC in children with ADHD.
- According to the "Alternative Medicine Review," use of OPC for ADHD is mostly based on anecdotal reports suggesting that symptoms improved while patients were taking OPC supplements.
OPC Supplements vs Stimulant Medications for ADHD
A preliminary study conducted by Dr. Marion Sigurdson, a psychologist, used an OPC supplement made from pine bark and grape seed to treat 30 children and adults with ADHD. She said it worked as well as stimulant medication in treating attention and behavior symptoms. Don't take or give your child any supplements without consulting a doctor or pediatrician, however, especially if other medicines have already been prescribed, because of the possibility of interactions.
- A preliminary study conducted by Dr. Marion Sigurdson, a psychologist, used an OPC supplement made from pine bark and grape seed to treat 30 children and adults with ADHD.
- She said it worked as well as stimulant medication in treating attention and behavior symptoms.
OPC and ADHD
Pycnogenol for ADHD
Learn More
Although studies have not shown how OPCs work to treat ADHD, lab studies have shown that OPCs may help regulate the neurotransmitters dopamine and norepinephrine, which are implicated in ADHD functioning. Dr. James Greenblatt, a physician at Comprehensive Psychiatric Resources Inc., says he has found in case studies at his clinic that children with ADHD show improvement in handwriting, behavior and school performance, and changes in EEG, when given OPC supplements. Despite these preliminary findings, no controlled clinical studies have been conducted on use of OPCs and ADHD, so while its use may prove beneficial, there is no definitive research support for it at this time. Check with your doctor if you have questions or are considering the supplement.
- Although studies have not shown how OPCs work to treat ADHD, lab studies have shown that OPCs may help regulate the neurotransmitters dopamine and norepinephrine, which are implicated in ADHD functioning.
- Dr. James Greenblatt, a physician at Comprehensive Psychiatric Resources Inc., says he has found in case studies at his clinic that children with ADHD show improvement in handwriting, behavior and school performance, and changes in EEG, when given OPC supplements.
Related Articles
References
- Alternative Medicine Review; Oligomeric Proanthocyanidins (OPCs); 2003
- Oligomeric Proanthocyanidin Complexes: History, Structure, and Phytopharmaceutical Applications
- Adler, L, Spencer, T. et al. Best practices in adult ADHD: Epidemiology, impairments, and differential diagnosis. CNS Spectr . 2008;13(S12):18-18. doi:10.1017/S1092852900003151
- Bruchmüller K, Margraf J, Schneider S. Is ADHD diagnosed in accord with diagnostic criteria? Overdiagnosis and influence of client gender on diagnosis. Journal of Consulting and Clinical Psychology. 80(1):128-138. doi:10.1037/a0026582
- Skogli EW, Teicher MH, Andersen PN, Hovik KT, Øie M. ADHD in girls and boys – gender differences in co-existing symptoms and executive function measures. BMC Psychiatry. 2013;13(1). doi:10.1186/1471-244X-13-298
- Fresson M, Meulemans T, Dardenne B, Geurten M. Overdiagnosis of ADHD in boys: Stereotype impact on neuropsychological assessment. Applied Neuropsychology: Child. 2019;8(3):231-245. doi:10.1080/21622965.2018.1430576
- Rucklidge JJ. Gender differences in attention-deficit/hyperactivity disorder. Psychiatric Clinics of North America. 2010;33(2):357-373. doi:10.1016/j.psc.2010.01.006.
- Visser SN, Danielson ML, Bitsko RH, et al. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry. 2014;53(1):34-46.e2. doi:10.1016/j.jaac.2013.09.001
- Russell AE, Ford T, Russell G. Socioeconomic associations with ADHD: Findings from a mediation analysis. PLoS ONE. 10(6):e0128248. doi:10.1371/journal.pone.0128248
- Paris J, Bhat V, Thombs B. Is adult attention-deficit hyperactivity disorder being overdiagnosed?. Can J Psychiatry. 2015;60(7):324-8. doi:10.1177/070674371506000705
- Coates J, Taylor JA, Sayal K. Parenting interventions for ADHD. J Atten Disord. 2015;19(10):831-843. doi:10.1177/1087054714535952
- Hansson Halleröd SL, Anckarsäter H, Råstam M, Hansson Scherman M. Experienced consequences of being diagnosed with ADHD as an adult – a qualitative study. BMC Psychiatry. 2015;15(1). doi:10.1186/s12888-015-0410-4
- Holbrook JR, Cuffe SP, Cai B, et al. Persistence of parent-reported ADHD symptoms from childhood through adolescence in a community sample. J Atten Disord. 2016;20(1):11-20. doi:10.1177/1087054714539997
- Miller DJ, Derefinko KJ, Lynam DR, Milich R, Fillmore MT. Impulsivity and attention deficit-hyperactivity disorder: Subtype classification using the UPPS impulsive behavior scale. J Psychopathol Behav Assess. 2010;32(3):323-332. doi:10.1007/s10862-009-9155-z
- Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159-165. doi:10.1017/S003329170500471X
- Turgay A, Goodman DW, Asherson P, et al. Lifespan persistence of ADHD. J Clin Psychiatry. 2012;73(02):192-201. doi:10.4088/JCP.10m06628
- Torrente F, Lischinsky A, Torralva T, López P, Roca M, Manes F. Not always hyperactive?: Elevated apathy scores in adolescents and adults with ADHD. J Atten Disord. 2011;15(7):545-556. doi:10.1177/1087054709359887
- Konrad K, Eickhoff SB. Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder. Hum Brain Mapp. 2010;31(6):904-916. doi:10.1002/hbm.21058
- Young S, Sedgwick O. Attention deficit hyperactivity disorder and substance misuse: an evaluation of causal hypotheses and treatment considerations. Expert Review of Neurotherapeutics. 2015;15(9):1005-1014. doi:10.1586/14737175.2015.1059756
- American Psychiatric Association, DSM-5 Task Force. Diagnostic And Statistical Manual Of Mental Disorders, DSM-5. Fifth Edition. Arlington, VA, US: American Psychiatric Association Publishing; 2013. doi:10.1176/appi.books.9780890425596
- Asherson P, Akehurst R, Kooij JJS, et al. Under diagnosis of adult ADHD. J Atten Disord. 2012;16(5_suppl):20S-38S. doi:10.1177/1087054714535952
- Bihlar Muld B, Jokinen J, Bölte S, Hirvikoski T. Long-term outcomes of pharmacologically treated versus non-treated adults with ADHD and substance use disorder: A naturalistic study. Journal of Substance Abuse Treatment. 2015;51:82-90. doi:10.1016/j.jsat.2014.11.005
- Brodersen J, Schwartz LM, Heneghan C, O’Sullivan JW, Aronson JK, Woloshin S. Overdiagnosis: What it is and what it isn’t. BMJ EBM. 2018;23(1):1-3. doi:10.1136/ebmed-2017-110886
- Child and Adolescent Health Measurement Initiative. National Outcome Measure 17.4: Percent of Children, Ages 3 through 17, Diagnosed with Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder (ADD/ADHD.; 2019). childhealthdata.org
- Coker TR, Elliott MN, Toomey SL, et al. Racial and ethnic disparities in ADHD diagnosis and treatment. PEDIATRICS. 2016;138(3):e20160407-e20160407. doi:10.1542/peds.2016-0407
- Derks EM, Hudziak JJ, Boomsma DI. Why more boys than girls with ADHD receive treatment: A study of dutch twins. Twin Res Hum Genet. 2007;10(5):765-770. doi:10.1375/twin.10.5.765
- Fayyad J, Sampson NA, Hwang I, et al. The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. ADHD Atten Def Hyp Disord. 2017;9(1):47-65. doi:10.1007/s12402-016-0208-3
- Lui JHL, Johnston C, Lee CM, Lee-Flynn SC. Parental ADHD symptoms and self-reports of positive parenting. Journal of Consulting and Clinical Psychology. 81(6):988-998. doi:10.1037/a0033490
- MANOS MJ, GIULIANO K, GEYER E. ADHD: Overdiagnosed and overtreated, or misdiagnosed and mistreated? Cleve Clin J Med. 2017;84(11):873-880. doi:10.3949/ccjm.84a.15051
- Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the overdiagnosis of ADHD. J Atten Disord. 2007;11(2):106-113. doi:10.1177/1087054707300094
- Wilens TE, Morrison NR. The intersection of attention-deficit/hyperactivity disorder and substance abuse. Current Opinion in Psychiatry. 2011;24(4):280-285. doi:10.1097/YCO.0b013e328345c956
Writer Bio
Rachel Elizabeth has been writing and editing since 2006. Her work appears in the academic journal "Teaching of Psychology," as well as on various websites. Rachel Elizabeth has a Doctor of Psychology from Widener University.